The Division of Drug Information (DDI) is CDER's focal point for public inquiries. We serve the public by providing information on human drug products and drug product regulation by FDA.
FDA Drug Info has posted new Drug Safety Podcasts. Click on the following links to listen to the podcasts and read the transcripts.
- Anti-seizure drug Potiga (ezogabine) linked to retinal abnormalities and blue skin discoloration
- FDA limits duration and usage of Samsca (tolvaptan) due to possible liver injury leading to organ transplant or death